Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -0.57%287.9B | 3.97%295.68B | 5.27%291.36B | 7.17%1.18T | 3.01%326.7B | 7.48%289.54B | 8.71%284.4B | 10.48%276.76B | 17.37%1.1T | 13.67%317.15B |
Cost of revenue | -0.19%204.57B | -3.33%207.95B | -3.49%202.34B | 0.65%850.9B | -10.57%221.18B | -4.19%204.95B | 5.84%215.11B | 15.86%209.66B | 25.00%845.44B | 21.96%247.32B |
Gross profit | -1.48%83.33B | 26.62%87.73B | 32.67%89.03B | 28.94%326.5B | 51.12%105.52B | 52.46%84.59B | 18.71%69.29B | -3.51%67.1B | -2.49%253.22B | -8.40%69.83B |
Operating expense | 89.81%113.8B | 10.35%66.48B | 15.16%68.33B | 9.98%262.01B | 27.52%82.48B | 2.98%59.95B | 0.45%60.25B | 7.17%59.34B | 13.16%238.23B | 13.61%64.68B |
Selling and administrative expenses | 7.39%64.11B | 14.02%68.62B | 11.36%65.84B | 7.60%248.83B | 15.90%69.82B | 4.21%59.7B | 2.06%60.19B | 7.98%59.13B | 11.33%231.26B | 6.94%60.24B |
-General and administrative expense | 7.39%64.11B | 14.02%68.62B | 11.36%65.84B | 7.60%248.83B | 15.90%69.82B | 4.21%59.7B | 2.06%60.19B | 7.98%59.13B | 11.33%231.26B | 6.94%60.24B |
Other operating expenses | 6,482.92%50.89B | 72.33%1.07B | 209.82%3.25B | 56.82%15.79B | 162.00%13.35B | -69.98%773M | -45.16%618M | -17.47%1.05B | 83.92%10.07B | 251.38%5.1B |
Total other operating income | 129.89%1.2B | 476.12%3.21B | -9.17%763M | -15.65%2.61B | 4.86%690M | -68.34%522M | 360.33%557M | 26.32%840M | 15.93%3.09B | -22.95%658M |
Operating profit | -223.68%-30.47B | 135.04%21.26B | 166.46%20.7B | 330.28%64.49B | 347.34%23.05B | 1,000.33%24.63B | 663.08%9.04B | -45.22%7.77B | -69.52%14.99B | -73.32%5.15B |
Net non-operating interest income (expenses) | -631.39%-15.49B | 561.80%6.48B | 345.90%5.17B | -123.70%-1.77B | 1.93%-6.83B | 2,370.34%2.92B | -90.28%979M | -72.72%1.16B | 266.47%7.48B | -25.64%-6.96B |
Non-operating interest income | -210.84%-7.87B | 220.42%8.9B | 135.56%6.88B | 3.59%11.93B | 130.35%1.68B | 483.00%7.1B | -77.09%2.78B | -41.42%2.92B | 541.01%11.52B | -171.58%-5.53B |
Non-operating interest expense | 82.01%7.62B | 34.54%2.42B | -2.72%1.72B | 239.15%13.71B | 495.94%8.5B | 280.55%4.19B | -12.25%1.8B | 138.24%1.76B | -35.74%4.04B | -59.25%1.43B |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | 662.50%45M | -133.33%-7M | 92.59%-2M | -63.01%27M | 65M | -117.39%-8M | -109.38%-3M | -440.00%-27M | -17.05%73M | 0 |
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | -266.71%-45.91B | 176.74%27.73B | 190.62%25.86B | 178.38%62.75B | 1,001.33%16.29B | 1,170.76%27.54B | 17.91%10.02B | -51.69%8.9B | -49.65%22.54B | -113.08%-1.81B |
Income tax | -255.97%-11.42B | 79.46%12.8B | -108.52%-359M | 140.39%24.24B | 164.09%5.57B | 2,388.44%7.32B | 231.51%7.13B | -31.39%4.22B | -31.77%10.08B | -63.26%2.11B |
Net income | -270.59%-34.49B | 417.30%14.92B | 459.80%26.22B | 209.14%38.51B | 373.82%10.72B | 997.74%20.22B | -54.53%2.89B | -61.85%4.68B | -58.46%12.46B | -148.46%-3.92B |
Net income continuous operations | -270.59%-34.49B | 417.30%14.92B | 459.80%26.22B | 209.14%38.51B | 373.82%10.72B | 997.74%20.22B | -54.53%2.89B | -61.85%4.68B | -58.46%12.46B | -148.46%-3.92B |
Noncontrolling interests | -84.27%190M | 179.39%1.04B | 103.54%1.38B | -52.06%1.46B | -15.83%877M | 114.56%1.21B | -243.09%-1.31B | 29.39%678M | 489.34%3.04B | 256.46%1.04B |
Net income attributable to the company | -282.43%-34.68B | 231.46%13.89B | 520.09%24.84B | 293.50%37.05B | 298.57%9.84B | 775.28%19.01B | -22.88%4.19B | -65.92%4.01B | -68.05%9.42B | -156.69%-4.96B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -282.43%-34.68B | 231.46%13.89B | 520.09%24.84B | 293.50%37.05B | 298.57%9.84B | 775.28%19.01B | -22.88%4.19B | -65.92%4.01B | -68.05%9.42B | -156.69%-4.96B |
Gross dividend payment | ||||||||||
Basic earnings per share | -282.44%-131.85 | 231.45%52.8 | 520.16%94.45 | 293.46%140.86 | 298.57%37.43 | 775.42%72.27 | -22.89%15.93 | -65.92%15.23 | -68.05%35.8 | -156.69%-18.85 |
Diluted earnings per share | -282.44%-131.85 | 231.45%52.8 | 520.16%94.45 | 293.46%140.86 | 298.53%37.4233 | 775.42%72.27 | -22.89%15.93 | -65.92%15.23 | -68.05%35.8 | -156.70%-18.85 |
Dividend per share | 0 | 480.00%29 | 0 | 65.71%58 | 253.33%53 | 0 | -75.00%5 | 0 | -36.36%35 | -50.00%15 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |